Cyclophosphamide-induced apoptosis in A431 cells is inhibited by fucosyltransferase IV

Journal of Cellular Biochemistry

Volumn 112, Issue 5, 2011, Pages 1376-1383

  Yang, Xuesong ^a   Liu, Yuejian ^a   Liu, Jiwei ^a   Wang, Xiaoqi ^b   Yan, Qiu ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

cell apoptosis; cyclophosphamide; ERK MAPK; fucosyltransferase IV; PI3K Akt

Indexed keywords

ANNEXIN; CASPASE 3; CYCLOPHOSPHAMIDE; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 4; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FAR WESTERN BLOTTING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD15; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CYCLOPHOSPHAMIDE; DRUG RESISTANCE, NEOPLASM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FUCOSYLTRANSFERASES; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; POLY(ADP-RIBOSE) POLYMERASES; SIGNAL TRANSDUCTION;

EID: 79953717753     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23054     Document Type: Article

References (53)

1. Abe Y, Matsumoto S, Kito K, Ueda N,. 2000. Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. J Biol Chem 275: 21525-21531. (Pubitemid 30481857)
2. Allahverdian S, Wojcik KR, Dorscheid DR,. 2006. Airway epithelial wound repair: Role of carbohydrate sialyl Lewisx. Am J Physiol Lung Cell Mol Physiol 291: L828-836. (Pubitemid 44498496)
3. Auner HW, Mazzarella L, Cook L, Szydlo R, Saltarelli F, Pavlu J, Bua M, Giles C, Apperley JF, Rahemtulla A,. 2010. High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma. Bone Marrow Transplant.
4. Baines CP, Molkentin JD,. 2005. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol 38: 47-62. (Pubitemid 40038651)
5. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME,. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868. (Pubitemid 29165088)
6. Cao Y, Merling A, Karsten U, Schwartz-Albiez R,. 2001. The fucosylated histo-blood group antigens H type 2 (blood group O, CD173) and Lewis Y (CD174) are expressed on CD34+ hematopoietic progenitors but absent on mature lymphocytes. Glycobiology 11: 677-683. (Pubitemid 32782685)
7. Chang HL, Sugimoto Y, Liu S, Wang LS, Huang YW, Ye W, Lin YC,. 2009. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells. Anticancer Res 29: 3195-3205.
8. Chen C, Liang W, Jia J, van Goor H, Singhal PC, Ding G,. 2009. Aldosterone induces apoptosis in rat podocytes: Role of PI3-K/Akt and p38MAPK signaling pathways. Nephron Exp Nephrol 113: e26-e34.
9. Cho SG, Choi EJ,. 2002. Apoptotic signaling pathways: Caspases and stress-activated protein kinases. J Biochem Mol Biol 35: 24-27.
10. Ciolczyk-Wierzbicka D, Bodzioch M, Gil D, Zmudzinska D, Dembinska-Kiec A, Laidler P,. 2007. Expression of fucosyltransferases contributes to melanoma invasive phenotype. Med Chem 3: 418-424. (Pubitemid 47455730)
11. Cotter TG,. 2009. Apoptosis and cancer: The genesis of a research field. Nat Rev Cancer 9: 501-507.
12. Dreyfuss JL, Regatieri CV, Jarrouge TR, Cavalheiro RP, Sampaio LO, Nader HB,. 2009. Heparan sulfate proteoglycans: Structure, protein interactions and cell signaling. An Acad Bras Cienc 81: 409-429.
13. Escrevente C, Machado E, Brito C, Reis CA, Stoeck A, Runz S, Marme A, Altevogt P, Costa J,. 2006. Different expression levels of alpha3/4 fucosyltransferases and Lewis determinants in ovarian carcinoma tissues and cell lines. Int J Oncol 29: 557-566.
14. Gatti L, Zunino F,. 2005. Overview of tumor cell chemoresistance mechanisms. Methods Mol Med 111: 127-148.
15. Harrington EA, Fanidi A, Evan GI,. 1994. Oncogenes and cell death. Curr Opin Genet Dev 4: 120-129. (Pubitemid 24060305)
16. Hector S, Prehn JH,. 2009. Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: A review. Biochim Biophys Acta 1795: 117-129.
17. Helenius A, Aebi M,. 2001. Intracellular functions of N-linked glycans. Science 291: 2364-2369. (Pubitemid 32231791)
18. Ishimaru D, Ramalingam S, Sengupta TK, Bandyopadhyay S, Dellis S, Tholanikunnel BG, Fernandes DJ, Spicer EK,. 2009. Regulation of Bcl-2 expression by HuR in HL60 leukemia cells and A431 carcinoma cells. Mol Cancer Res 7: 1354-1366.
19. Ito H, Hiraiwa N, Sawada-Kasugai M, Akamatsu S, Tachikawa T, Kasai Y, Akiyama S, Ito K, Takagi H, Kannagi R,. 1997. Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal cancer tissues. Int J Cancer 71: 556-564. (Pubitemid 27239364)
20. Jin Z, El-Deiry WS,. 2005. Overview of cell death signaling pathways. Cancer Biol Ther 4: 139-163. (Pubitemid 41351311)
21. Kang MH, Reynolds CP,. 2009. Bcl-2 inhibitors: Targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 15: 1126-1132.
22. Kolasa IK, Rembiszewska A, Felisiak A, Ziolkowska-Seta I, Murawska M, Moes J, Timorek A, Dansonka-Mieszkowska A, Kupryjanczyk J,. 2009. PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients. Cancer Biol Ther 8: 21-26.
23. Kudo T, Ikehara Y, Togayachi A, Morozumi K, Watanabe M, Nakamura M, Nishihara S, Narimatsu H,. 1998. Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Lab Invest 78: 797-811. (Pubitemid 28347877)
24. Li Z, Wang H, Zong H, Sun Q, Kong X, Jiang J, Gu J,. 2005. Downregulation of beta1,4-galactosyltransferase 1 inhibits CDK11(p58)-mediated apoptosis induced by cycloheximide. Biochem Biophys Res Commun 327: 628-636. (Pubitemid 40040520)
25. Low SK, Kiyotani K, Mushiroda T, Daigo Y, Nakamura Y, Zembutsu H,. 2009. Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients. J Hum Genet 54: 564-571.
26. Lowe SW, Lin AW,. 2000. Apoptosis in cancer. Carcinogenesis 21: 485-495. (Pubitemid 30137934)
27. Lusis AJ,. 2000. Atherosclerosis. Nature 407: 233-241.
28. Ma B, Simala-Grant JL, Taylor DE,. 2006. Fucosylation in prokaryotes and eukaryotes. Glycobiology 16: 158R-184R. (Pubitemid 44811579)
29. Margolin S, Bengtsson NO, Carlsson L, Edlund P, Hellstrom M, Karlsson P, Lidbrink E, Linderholm B, Lindman H, Malmstrom P, Pettersson Skold D, Soderberg M, Villman K, Bergh J,. 2010. A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer. Acta Oncol 50: 35-41.
30. Martin-Satue M, Marrugat R, Cancelas JA, Blanco J,. 1998. Enhanced expression of alpha(1,3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells. Cancer Res 58: 1544-1550. (Pubitemid 28193622)
31. Matsumoto K, Yokote H, Arao T, Maegawa M, Tanaka K, Fujita Y, Shimizu C, Hanafusa T, Fujiwara Y, Nishio K,. 2008. N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor. Cancer Sci 99: 1611-1617.
32. Moore GT, Brown SJ, Winterhalter AC, Lust M, Salvaris EJ, Selan C, Nandurkar HH, Desmond PV, Cowan PJ, d'Apice AJ,. 2008. Glycosylation changes in hFUT1 transgenic mice increase TCR signaling and apoptosis resulting in thymocyte maturation arrest. Mol Immunol 45: 2401-2410.
33. Mullonkal CJ, Toledo-Pereyra LH,. 2007. Akt in ischemia and reperfusion. J Invest Surg 20: 195-203. (Pubitemid 47050383)
34. Pang LP, Huang W, Sun Q, Guo W, Li RT, Cui JR,. 2008. SLXM-2, a derivative of cyclophosphamide: Mechanism of growth inhibition on hepatocarcinoma 22 cells. Anticancer Drugs 19: 167-174.
35. Petretti T, Schulze B, Schlag PM, Kemmner W,. 1999. Altered mRNA expression of glycosyltransferases in human gastric carcinomas. Biochim Biophys Acta 1428: 209-218. (Pubitemid 29352268)
36. Prasad S, Madan E, Nigam N, Roy P, George J, Shukla Y,. 2009. Induction of apoptosis by lupeol in human epidermoid carcinoma A431 cells through regulation of mitochondrial, Akt/PKB and NFkappaB signaling pathways. Cancer Biol Ther 8: 1632-1639.
37. Rokhlin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, Kiefer MC, Umansky SR, Glover RA, Cohen MB,. 1997. Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 57: 1758-1768. (Pubitemid 27199671)
38. Schey SA, Morgan GJ, Ramasamy K, Hazel B, Ladon D, Corderoy S, Jenner M, Phekoo K, Boyd K, Davies FE,. 2010. The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II study. Br J Haematol 150: 326-333.
39. Schulze-Bergkamen H, Krammer PH,. 2004. Apoptosis in cancer-Implications for therapy. Semin Oncol 31: 90-119.
40. Singh N, Nigam M, Ranjan V, Sharma R, Balapure AK, Rath SK,. 2009. Caspase mediated enhanced apoptotic action of cyclophosphamide- and resveratrol-treated MCF-7 cells. J Pharmacol Sci 109: 473-485.
41. Skaug B, Jiang X, Chen ZJ,. 2009. The role of ubiquitin in NF-kappaB regulatory pathways. Annu Rev Biochem 78: 769-796.
42. Taniguchi A, Suga R, Matsumoto K,. 2000. Expression and transcriptional regulation of the human alpha1,3-fucosyltransferase 4 (FUT4) gene in myeloid and colon adenocarcinoma cell lines. Biochem Biophys Res Commun 273: 370-376. (Pubitemid 30426913)
43. Vermeulen K, Van Bockstaele DR, Berneman ZN,. 2005. Apoptosis: Mechanisms and relevance in cancer. Ann Hematol 84: 627-639. (Pubitemid 41554237)
44. Wagner EF, Nebreda AR,. 2009. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549.
45. Wang H, Ge CH, Kong Y, Xin Y, Zhu ZM,. 2001. Ovary hormonal control of Le(y) oligosaccharide expression during peri-implantation of mouse endometrium. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 33: 542-546. (Pubitemid 33339142)
46. Wang H, Wang QY, Zhang Y, Shen ZH, Chen HL,. 2007. Alpha1,3 fucosyltransferase-VII modifies the susceptibility of apoptosis induced by ultraviolet and retinoic acid in human hepatocarcinoma cells. Glycoconj J 24: 207-220. (Pubitemid 46866642)
47. Watson JL, Greenshields A, Hill R, Hilchie A, Lee PW, Giacomantonio CA, Hoskin DW,. 2009. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Mol Carcinog
48. Winkler IG, Snapp KR, Simmons PJ, Levesque JP,. 2004. Adhesion to E-selectin promotes growth inhibition and apoptosis of human and murine hematopoietic progenitor cells independent of PSGL-1. Blood 103: 1685-1692. (Pubitemid 38268960)
49. Yang X, Zhang Z, Jia S, Liu Y, Wang X, Yan Q,. 2007. Overexpression of fucosyltransferase IV in A431 cell line increases cell proliferation. Int J Biochem Cell Biol 39: 1722-1730. (Pubitemid 47088316)
50. Yang XS, Liu S, Liu YJ, Liu JW, Liu TJ, Wang XQ, Yan Q,. 2010. Overexpression of fucosyltransferase IV promotes A431 cell proliferation through activating MAPK and PI3K/Akt signaling pathways. J Cell Physiol 225: 612-619.
51. Zhang T, Yang D, Fan Y, Xie P, Li H,. 2009. Epigallocatechin-3-gallate enhances ischemia/reperfusion-induced apoptosis in human umbilical vein endothelial cells via AKT and MAPK pathways. Apoptosis 14: 1245-1254.
52. Zhang Z, Sun P, Liu J, Fu L, Yan J, Liu Y, Yu L, Wang X, Yan Q,. 2008. Suppression of FUT1/FUT4 expression by siRNA inhibits tumor growth. Biochim Biophys Acta 1783: 287-296.
53. Zhao LJ, Xu YH, Li Y,. 2009. Effect of parthenolide on proliferation and apoptosis in gastric cancer cell line SGC7901. J Dig Dis 10: 172-180.